GREENLITE VENTURES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GREENLITE VENTURES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | $0 | Jul 13, 2012 |
| FY2011 | Mar 31, 2011 | $0 | Jul 13, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | ($199.8K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2011 | ($69.1K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2010 | ($67.9K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2009 | ($51.0K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2008 | ($71.8K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2007 | ($52.3K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2006 | ($49.1K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2005 | ($46.1K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2004 | ($45.7K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2003 | ($29.2K) | Jul 13, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | $0 | Jul 13, 2012 |
| FY2011 | Mar 31, 2011 | $0 | Jul 13, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | ($41.3K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2011 | ($38.6K) | Jul 13, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | $164.8K | Jul 13, 2012 |
| FY2011 | Mar 31, 2011 | $64.3K | Jul 13, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | $1.0K | Jul 13, 2012 |
| FY2011 | Mar 31, 2011 | ($159.2K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2010 | ($150.1K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2008 | ($31.3K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2007 | ($49.5K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2006 | $2.8K | Jul 13, 2012 |
| FY2011 | Mar 31, 2005 | ($8.1K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2004 | ($7.0K) | Jul 13, 2012 |
| FY2011 | Mar 31, 2003 | $38.7K | Jul 13, 2012 |
| FY2011 | Mar 31, 2002 | ($2.1K) | Jul 13, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | 0 | Jul 13, 2012 |
| FY2011 | Mar 31, 2011 | 0 | Jul 13, 2012 |